Paul Whitaker
Overview
Explore the profile of Paul Whitaker including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
53
Citations
484
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Whitaker P, Gibson A, Farrell J, Gillgrass L, Meng X, Peckham D, et al.
J Allergy Clin Immunol Pract
. 2024 Dec;
13(3):594-609.e8.
PMID: 39674278
Background: Piperacillin-tazobactam is used in patients with cystic fibrosis to treat recurrent respiratory infections. Exposure is associated with a high frequency of nonimmediate hypersensitivity. Objective: To assess the applicability of...
2.
Ariza A, Jaruthamsophon K, Meng X, Labella M, Adair K, Tailor A, et al.
Chem Res Toxicol
. 2022 Sep;
35(11):2122-2132.
PMID: 36137197
β-Lactamase inhibitors such as clavulanic acid and tazobactam were developed to overcome β-lactam antibiotic resistance. Hypersensitivity reactions to these drugs have not been studied in detail, and the antigenic determinants...
3.
Tanno L, Whitaker P
Curr Opin Allergy Clin Immunol
. 2022 Jul;
22(4):213-214.
PMID: 35852894
No abstract available.
4.
Craig A, Asmar S, Whitaker P, Shaw D, Saralaya D
Bone Jt Open
. 2022 May;
3(5):432-440.
PMID: 35608348
Aims: Tuberculosis (TB) is one of the biggest communicable causes of mortality worldwide. While incidence in the UK has continued to fall since 2011, Bradford retains one of the highest...
5.
Blanca M, Whitaker P
Curr Opin Allergy Clin Immunol
. 2021 Jun;
21(4):317-319.
PMID: 34183504
No abstract available.
6.
Waddington J, Ali S, Penman S, Whitaker P, Hamlett J, Chadwick A, et al.
Chem Res Toxicol
. 2020 Nov;
33(12):2939-2943.
PMID: 33169987
Flucloxacillin is a β-lactam antibiotic associated with a high incidence of drug-induced liver reactions. Although expression of HLA-B*57:01 increases susceptibility, little is known about the pathological mechanisms involved in the...
7.
Spoletini G, Pollard K, Watson R, Darby M, Johnstone A, Etherington C, et al.
Respir Care
. 2020 Sep;
66(3):466-474.
PMID: 32900912
Background: Noninvasive ventilation (NIV) is routinely used to treat patients with cystic fibrosis and respiratory failure. However, evidence on its use is limited, with no data on its role in...
8.
Waddington J, Meng X, Illing P, Tailor A, Adair K, Whitaker P, et al.
Toxicol Sci
. 2020 Jul;
177(2):454-465.
PMID: 32726429
Flucloxacillin is a β-lactam antibiotic associated with a high incidence of drug-induced liver reactions. Although expression of human leukocyte antigen (HLA)-B*57:01 increases susceptibility, little is known of the pathological mechanisms...
9.
Blanca M, Whitaker P
Curr Opin Allergy Clin Immunol
. 2020 Jun;
20(4):331-332.
PMID: 32590500
No abstract available.
10.
Lipman M, Cleverley J, Fardon T, Musaddaq B, Peckham D, van der Laan R, et al.
BMJ Open Respir Res
. 2020 Jun;
7(1).
PMID: 32565445
A rising number of non-tuberculous mycobacterial (NTM) isolates are being identified in UK clinical practice. There are many uncertainties around the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD), including its...